Admission Date:  [**2139-5-13**]              Discharge Date:   [**2139-5-17**]  Date of Birth:  [**2066-4-30**]             Sex:   M  Service: MEDICINE  Allergies: Amoxicillin  Attending:[**Last Name (NamePattern1) 1167**] Chief Complaint: DOE  Major Surgical or Invasive Procedure: Cardiac Catheterization s/t stent placement to ramus and LIMA anastamosis Swan [**Last Name (un) 26645**] Catheter Placement   History of Present Illness: 73YO male with hx CAD s/p CABG with redo [**2120**], CHF with EF 30%, afib, DM, CRI, PVD who has recent [**Hospital1 18**] stay last month for decompensated heart failure and ARF that required CCU stay for tailored therapy and CVVH presents today with worsening DOE.
He had a stress test just 4 days ago that showed defects and is aware that cath is planned for him in the near future.
Past Medical History: CAD (CABG [**2109**] AND [**2120**]) CHF w/ EF 30%, diastolic dysfx - recent admit with CCU transfer for tailored therapy [**3-30**].
His wedge was 33, PAP 63/29, cardiac output 4.4, cardiac index 2.07.
He was stabilized and transferred back to a floor where he was maintained on Lasix and metolazone with good urine output and faily stable renal function.
Physical Exam: Gen: pleasant, comfortable, mild SOB VS: 98.0 67 94/31 17 100% HEENT: EOMI, anicteric, mild sclerae injection, MMM Neck: supple, JVP at 11-12, no LAD lungs: left basilar rales otherwise CTA bilaterally heart: irregular, HSM across precordium greatest at LSB abd; soft NT ND -h/s megaly, midline hernia with scar ext: 3+ edema bilaterally but L>R (pt states chronic) neuro: CN intact, A&OX3   Pertinent Results: [**2139-5-13**] 11:00PM   CK(CPK)-81 [**2139-5-13**] 11:00PM   CK-MB-NotDone cTropnT-0.44* [**2139-5-13**] 04:19PM   CK(CPK)-106 [**2139-5-13**] 04:19PM   CK-MB-12* MB INDX-11.3* cTropnT-0.52* [**2139-5-13**] 04:19PM   PT-21.2* PTT-37.4* INR(PT)-2.1* [**2139-5-13**] 02:00PM   PT-42.4* PTT-44.4* INR(PT)-4.8* [**2139-5-13**] 01:20PM   CK(CPK)-117 [**2139-5-13**] 01:20PM   CK-MB-15* MB INDX-12.8* cTropnT-0.48* [**2139-5-13**] 01:20PM   PT-40.1* PTT-39.8* INR(PT)-4.5* [**2139-5-13**] 08:50AM   GLUCOSE-137* UREA N-115* CREAT-2.7* SODIUM-137 POTASSIUM-3.2* CHLORIDE-96 TOTAL CO2-26 ANION GAP-18 [**2139-5-13**] 08:50AM   CK(CPK)-120 [**2139-5-13**] 08:50AM   CK-MB-16* MB INDX-13.3* cTropnT-0.40* [**2139-5-13**] 08:50AM   PLT COUNT-104* [**2139-5-13**] 08:50AM   PT-45.6* PTT-40.8* INR(PT)-5.3* [**2139-5-13**] 07:01AM URINE  HOURS-RANDOM UREA N-521 CREAT-69 SODIUM-63 albumin-2.9 alb/CREA-42.0* [**2139-5-13**] 07:01AM URINE  OSMOLAL-373 [**2139-5-13**] 07:01AM URINE  COLOR-Straw APPEAR-Clear SP [**Last Name (un) 155**]-1.010 [**2139-5-13**] 07:01AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG [**2139-5-12**] 10:15PM   GLUCOSE-274* UREA N-119* CREAT-3.0* SODIUM-134 POTASSIUM-4.3 CHLORIDE-92* TOTAL CO2-28 ANION GAP-18 [**2139-5-12**] 10:15PM   ALT(SGPT)-24 AST(SGOT)-22 LD(LDH)-208 CK(CPK)-93 ALK PHOS-144* TOT BILI-0.4 [**2139-5-12**] 10:15PM   cTropnT-0.08* [**2139-5-12**] 10:15PM   CK-MB-NotDone proBNP-5593* [**2139-5-12**] 10:15PM   ALBUMIN-3.8 [**2139-5-12**] 10:15PM   DIGOXIN-1.5 [**2139-5-12**] 10:15PM   WBC-7.5 RBC-3.18* HGB-10.5* HCT-30.9* MCV-97 MCH-32.9* MCHC-33.9 RDW-15.8* [**2139-5-12**] 10:15PM   NEUTS-82.5* LYMPHS-10.5* MONOS-5.6 EOS-0.8 BASOS-0.5 [**2139-5-12**] 10:15PM   MACROCYT-1+ [**2139-5-12**] 10:15PM   PLT COUNT-114* [**2139-5-12**] 10:15PM   PT-49.7* PTT-41.4* INR(PT)-5.9* [**2139-5-12**] 01:15PM   UREA N-108* CREAT-2.8* SODIUM-137 POTASSIUM-3.8 CHLORIDE-93* TOTAL CO2-29 ANION GAP-19 [**2139-5-12**] 01:15PM   MAGNESIUM-2.0 [**2139-5-12**] 01:15PM   DIGOXIN-1.7 [**2139-5-12**] 01:15PM   WBC-7.5 RBC-3.18* HGB-10.5* HCT-31.0* MCV-97 MCH-33.0* MCHC-33.9 RDW-16.0* [**2139-5-12**] 01:15PM   PLT COUNT-134* [**2139-5-12**] 01:15PM   PT-43.2* INR(PT)-4.9* .
[**2139-5-14**] BRIEF HISTORY:   73 year old male with ischemic cardiomyopathy (EF 20%) referred for cardiac catheterization for non-ST elevation MI.
HI last catheterization was on [**2131-4-12**] that showed left dominant system with patent LMCA and ramus only, otherwise occluded LAD, LCX, and RCA.
The LIMA-LAD, SVG-OM, and SVG-PDA were all patent.
Coronary Angiography: was performed in multiple projections using a 5 French JL4 and a 5 French JR4 catheter, with manual contrast injections.
Graft Angiography: of 2 saphenous vein bypass grafts was performed using a 5 French right [**Last Name (un) 2699**] catheter, with manual contrast injections.
Conscious Sedation:  was provided with appropriate monitoring performed by a member of the nursing staff.
HEMODYNAMICS RESULTS BODY SURFACE AREA:  2.02 m2   HEMOGLOBIN: 10.2 gms %   FICK **PRESSURES RIGHT ATRIUM {a/v/m} 22/24/21 RIGHT VENTRICLE {s/ed} 67/22 PULMONARY ARTERY {s/d/m} 64/30/40 PULMONARY WEDGE {a/v/m} 33/36/30 AORTA {s/d/m} 119/50/64 **CARDIAC OUTPUT HEART RATE {beats/min} 53 RHYTHM SINUS O2 CONS.
IND {ml/min/m2} 125 A-V O2 DIFFERENCE {ml/ltr} 55 CARD.
OP/IND FICK {l/mn/m2} 4.6/2.3 **RESISTANCES SYSTEMIC VASC.
FROM **LEFT CORONARY 5) LEFT MAIN   NORMAL 6) PROXIMAL LAD   DISCRETE 100 11) INTERMEDIUS   DISCRETE 90 12) PROXIMAL CX   DISCRETE 100  **ARTERIOGRAPHY RESULTS TO SEGMENTS MORPHOLOGY % STENOSIS LOCATION **BYPASS GRAFT 28) SVBG #1   17 NORMAL 29) SVBG #2   14 DISCRETE 100 32) LIMA   7 NORMAL   COMMENTS: 1.
The LAD, LCX, and RCA all had proximal occlusion.
Selective arterial conduit angiography revealed patent LIMA-LAD with 90% distal anastomosis stenosis.
Right costophrenic angle has been excluded from the study and cannot be assessed.
[**2139-5-16**] CXR INDICATION: 72-year-old man with CHF.
COMMENTS: Portable erect AP radiograph of the chest is reviewed, and compared with the previous study of [**2139-5-14**].
[**2139-5-17**] CXR COMMENTS: Portable erect AP radiograph of the chest is reviewed, and compared with the previous study of yesterday.
Patient was then transferred to the CCU for further monitoring and diuretic therapy.
HCT 25 and recieved 2 units PRBC's without complications, lasix IV in between units.
An ECHO is planned as an outpatient to see if EF has improved now that he is s/p intervention.
Renal team followed patient and decided CVVH was not necessary during this admission.
Discharge Instructions: Weigh yourself every morning, [**Name8 (MD) 138**] MD if weight > 3 lbs.
Adhere to 2 gm sodium diet Fluid Restriction: 1 liter Please note the following changes in your medications: 1) Plavix 75 mg PO QD to prevent clots after stent placement 2) Coreg 6.25 mg PO BID to help with blood pressure and cardiac function 3) Increase ASA to 162 mg PO QD from 81 mg PO QD 4) Digoxin has been changed from 125mcg every day to 125mcg every other day  Followup Instructions: Provider: [**Last Name (NamePattern4) **].
